epigallocatechin gallate has been researched along with arachidonic acid in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Hishinuma, T; Ishizawa, F; Mizugaki, M; Yamazaki, T | 1 |
| Bai, N; Ho, CT; Hong, J; Li, C; Lu, H; Meng, X; Patten, C; Sang, S; Sheng, S; Winnik, B; Yang, CS | 1 |
| Cederbaum, AI; Jimenez-Lopez, JM | 1 |
| Adhami, VM; Gupta, S; Hussain, T; Mukhtar, H | 1 |
| Ho, CT; Hong, J; Kwon, SJ; Lambert, JD; Lee, MJ; Sang, S; Yang, CS | 1 |
| Bayer, DK; Beltz, LA; Moss, AL; Simet, IM | 1 |
| Cho, MR; Han, XH; Im, JH; Jin, YR; Kim, TJ; Lee, JJ; Lim, Y; Park, ES; Yun, YP | 1 |
| Chalimoniuk, M; Cui, J; Ding, S; Gu, Z; He, Y; Lee, JC; Simonyi, A; Sun, AY; Sun, GY; Weisman, GA; Wood, WG | 1 |
| Chan, CL; Ho, HM; Hu, P; Jiang, ZH; Liu, L; Wang, JR; Yau, LF; Zhang, H | 1 |
1 review(s) available for epigallocatechin gallate and arachidonic acid
| Article | Year |
|---|---|
Mechanisms of cancer prevention by green and black tea polyphenols.
Topics: Animals; Antioxidants; Apoptosis; Arachidonic Acid; Catechin; Cell Cycle; Cell Proliferation; fas Receptor; Flavonoids; Gene Expression; Humans; Lipid Peroxidation; Lipoproteins, LDL; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; NF-kappa B; Nitric Oxide; Oncogenes; Oxidation-Reduction; Phenols; Polyphenols; Proteasome Inhibitors; Reactive Oxygen Species; Receptors, Androgen; Receptors, Aryl Hydrocarbon; Receptors, Growth Factor; Tea; Telomere; Tetrahydrofolate Dehydrogenase | 2006 |
9 other study(ies) available for epigallocatechin gallate and arachidonic acid
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Epigallocatechin gallate increase the prostacyclin production of bovine aortic endothelial cells.
Topics: Animals; Arachidonic Acid; Catechin; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Eicosapentaenoic Acid; Endothelium, Vascular; Epoprostenol; Fibrinolytic Agents; Gallic Acid; Gas Chromatography-Mass Spectrometry; Molecular Structure; Platelet Aggregation Inhibitors; Thromboxanes | 2000 |
Glucuronides of tea catechins: enzymology of biosynthesis and biological activities.
Topics: Animals; Arachidonic Acid; Catechin; Cells, Cultured; Chromatography, High Pressure Liquid; Colonic Neoplasms; Cytosol; Dose-Response Relationship, Drug; Female; Gas Chromatography-Mass Spectrometry; Glucuronides; Glucuronosyltransferase; Humans; In Vitro Techniques; Insecta; Intestinal Mucosa; Intestines; Kinetics; Liver; Male; Mice; Mice, Inbred Strains; Microsomes; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley; Species Specificity | 2003 |
Green tea polyphenol epigallocatechin-3-gallate protects HepG2 cells against CYP2E1-dependent toxicity.
Topics: Arachidonic Acid; Carcinoma, Hepatocellular; Catalysis; Catechin; Cell Line, Tumor; Cytochrome P-450 CYP2E1; Glutathione; Hepatocytes; Humans; Iron; Lipid Peroxidation; Mitochondria; Phenols; Protective Agents; Reactive Oxygen Species; Tea | 2004 |
Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Arachidonic Acid; Catechin; Cell Division; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Humans; Isoenzymes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tea; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2005 |
Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate.
Topics: Acetates; Acetylation; Animals; Anticarcinogenic Agents; Arachidonic Acid; Biological Availability; Catechin; Cell Line, Tumor; Cell Proliferation; Colon; Esterases; Humans; Intestine, Small; Male; Mice; Mice, Inbred Strains; Nitric Oxide | 2006 |
Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity.
Topics: Animals; Arachidonic Acid; Calcium-Transporting ATPases; Catechin; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Male; Phospholipase C gamma; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin D2; Rabbits; Rats; Rats, Sprague-Dawley; Tea | 2008 |
Prolonged exposure of cortical neurons to oligomeric amyloid-β impairs NMDA receptor function via NADPH oxidase-mediated ROS production: protective effect of green tea (-)-epigallocatechin-3-gallate.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Arachidonic Acid; Calcium; Catechin; Cell Survival; Cells, Cultured; Cerebral Cortex; Drug Interactions; Embryo, Mammalian; Glycoproteins; L-Lactate Dehydrogenase; N-Methylaspartate; NADPH Oxidases; Neurons; Neuroprotective Agents; Oxazines; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Tetrazolium Salts; Thiazoles; Time Factors; Xanthenes | 2011 |
A cellular lipidomic study on the Aβ-induced neurotoxicity and neuroprotective effects of EGCG by using UPLC/MS-based glycerolipids profiling and multivariate analysis.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Arachidonic Acid; Catechin; Glycerides; Lipid Metabolism; Multivariate Analysis; Neurons; Neuroprotective Agents; PC12 Cells; Peptide Fragments; Phosphatidylcholines; Phospholipases A2; Phospholipids; Principal Component Analysis; Rats | 2012 |